HomeCompareMSON vs NOBL

MSON vs NOBL: Dividend Comparison 2026

MSON yields 7.54% · NOBL yields 2.17%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MSON wins by $10.0K in total portfolio value
10 years
MSON
MSON
● Live price
7.54%
Share price
$26.54
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$32.9K
Annual income
$1,215.03
Full MSON calculator →
NOBL
NOBL
● Live price
2.17%
Share price
$104.67
Annual div
$2.27
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.9K
Annual income
$249.78
Full NOBL calculator →

Portfolio growth — MSON vs NOBL

📍 MSON pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMSONNOBL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MSON + NOBL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MSON pays
NOBL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MSON
Annual income on $10K today (after 15% tax)
$640.54/yr
After 10yr DRIP, annual income (after tax)
$1,032.78/yr
NOBL
Annual income on $10K today (after 15% tax)
$184.52/yr
After 10yr DRIP, annual income (after tax)
$212.31/yr
At 15% tax rate, MSON beats the other by $820.46/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MSON + NOBL for your $10,000?

MSON: 50%NOBL: 50%
100% NOBL50/50100% MSON
Portfolio after 10yr
$27.9K
Annual income
$732.40/yr
Blended yield
2.62%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MSON right now

MSON
Analyst Ratings
2
Buy
3
Hold
Consensus: Hold
NOBL
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MSON buys
0
NOBL buys
0
No recent congressional trades found for MSON or NOBL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMSONNOBL
Forward yield7.54%2.17%
Annual dividend / share$2.00$2.27
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$32.9K$22.9K
Annual income after 10y$1,215.03$249.78
Total dividends collected$9.9K$2.3K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: MSON vs NOBL ($10,000, DRIP)

YearMSON PortfolioMSON Income/yrNOBL PortfolioNOBL Income/yrGap
1← crossover$11,454$753.58$10,917$217.08+$537.00MSON
2$13,062$806.65$11,903$221.48+$1.2KMSON
3$14,836$859.75$12,962$225.68+$1.9KMSON
4$16,787$912.63$14,099$229.68+$2.7KMSON
5$18,927$965.10$15,319$233.49+$3.6KMSON
6$21,269$1,016.96$16,628$237.10+$4.6KMSON
7$23,826$1,068.02$18,033$240.53+$5.8KMSON
8$26,612$1,118.14$19,539$243.78+$7.1KMSON
9$29,642$1,167.18$21,154$246.86+$8.5KMSON
10$32,932$1,215.03$22,884$249.78+$10.0KMSON

MSON vs NOBL: Complete Analysis 2026

MSONStock

Misonix, Inc., together with its subsidiaries, designs, develops, manufactures, and markets minimally invasive surgical ultrasonic medical devices in the United States and internationally. The company's products include BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting and sculpting of bone while sparing soft tissue; SonaStar, a surgical aspirator that is used to emulsify and remove soft and hard tumors primarily in the neuro and general surgery field; and SonicOne, an ultrasonic cleansing and debridement system, which provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells. Its products are used in various clinical specialties, such as neurosurgery, orthopedic surgery, general surgery, plastic surgery, wound care, and maxillo-facial surgical applications. The company sells its products through sales representatives and distributors. Misonix, Inc. was founded in 1959 and is based in Farmingdale, New York.

Full MSON Calculator →

NOBLETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →
📬

Get this MSON vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MSON vs SCHDMSON vs JEPIMSON vs OMSON vs KOMSON vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.